levels (8 a.m.:31.3 dml) ad maintenance of a circadian rhythn w r e int e tirely consistent with C D, kt gocd F-suppression b y 0.5 q Dexmthasm or 1500 q M and adrenal stirmlation b y A C T H an3 C R F -via A C T K-indicated a central origin of hypercortisolim,. 24hsecretion of gonadotropins was stpp ressed and hypcpulsatile; H G H was redvced durirg sleep and after G H R Hstirmlation. After a Cmththerapy with 2 x 250 q M, the follcwiw changes wre wasured: decrease of rn 24h plam F (3.7 w/ml i 37%) and D H E A S (4406 vs 3333 nglml); slight elevation of A C T ti (40.1 pg/ml) and increase of testostem (0.59 vs 4.9 nglml, LH (1.8 vs 7.1 ng/ml), F S H (3.9 vs 6.7 d m l ) ad H G H (max. mturnal peak: 10.5 vs 18 ng/ml). Noml renine activity ad high smtmdin C w r e unchanged. Clinically the patient exhi- Cushing's syndrome is frequently associated with growth retardation and decreased gonadal function. So far, the underlying mechanisms of these disturbances are poorly understood. An 18 year old boy is described who was referred becausa of delayed puberty (bone age 12 years) and short stature (145.5 cm). The patient had a typical cushingoid habitus. His testes were preadolescent in size (4-5 ml), and the testosterone was low (18 ng/dl). 24h plasma cortisol levels were consistently high (32.3 k 5 ~lg/dl) with episodic increases. ACTtI was elevated (126 + 44.6 pg/ml), and the cortisol spikes could be related to concomitant ACTH bursts. 24h profiles of LH and HCH exhibited low levels (LH, 2.52 ? 0.51 mU/ml; HGH, 0.58 + 0.5 ng/ml), and t'ne pulsatile secretion was completely abolished. HGH failed to respond to arginine infusion, insulin-induced hypoglycemia, and GRFI-44. LHRH-stimulation produced a prepubertal increase of LH: 0 min, 2.95 mU/ml; 30 min, 8.2 mU/ml. Surgery revealed an ACTH-producing microadenoma of the pituitary. 3 months after complete extirpation of the tumor LH and tiGH showed normal pulsatile secretion patterns (9 pulses per 2 1 1 h), and testosterone had begun to normalize (414 ng/dl). After 1 year of observation, testicular size was 12-15 ml, and growth velocity was 10.6 cm/year. It is suggested that the delay of puberty and growth was due to the suppression of the pulsatile secretion of LH and HGH, caused by the hypercortisolism.
J. Girard, A.M. Landolt*, A. Valavanis*, A.N. Eberle, A. Pampalone*, and M. Zachmann (Introd. by J. Girard). University Children's Hospitals, and University Hospi-145 tals, Basel and ZJrich, Switzerland.
CUSHING'S SYNDROME, 1DENTlFlCATlON OF ACTH SOURCE BY SELECTIVE CATHETERIZATION AND ACTH ANDD-LPH ASSAYS
The differential diagnosis of ACTH dependent Cushing's syndrome (85% of patients) can be very difficult. Localization of an ACTH source is not always possible with CAT-scan and MRI imaging. A bilateral catheterization of the inferior petrosal sinus with blood sampling for ACTHILPH during a CRH test has been used for localizing a pituitary adenoma. ACTH was measured with a solid-phase antiserum against the 11-24 sequence of ACTH (sensitivity 16-32 pg/ml). Forp-LPH, the reagents of NIAMDD have been used. Samples were obtained before and at 5-min. intervals for up to 30 min. after injection of CRH, 100 ug/1.73 m2. In 18 of 21 patients, a pituitary ACTH source could be proven and in 16 an adenoma localized. In 12 of 18, peripheral ACTH levels were <I00 pg/ml (6 <40 pg/ ml). Mean basal/peak ACTH (LPH) pg/ml: Periphery 871256 (551/845), tumorside 899/1870 (3424/11572), contralateral 427/647 (1467/ 2034). In 6 of 18 patients, only CRH stimulated levels pointed to the correct side. The mean aACTH (LPH)(ipsilateral to contralateral) increased from 172 (1957) before to 1223 (9529) after CRH. In conclusion, selective catheterization and ACTHILPH assay after CRH is valuable for detecting the ACTH source and thus allows a selective surgery, preserving the pituitary tissue, which is of outmost importance, especially in the pediatric age group.
M . Damkjgr Nielsen , K.E. Petersen and S. Krabbe AGE ZTHF THS ZTHB P-trio1 A-5-P-trio1 17KS 16-OH-OHA C. P-triol, A-5-P-triol, 17KS and 16-OH-DHA were highly increased in the carcinoma patients. Distinction between malignant and benign tumor was therefore possible, whereas no distinction between adenoma a n d micronodular dysplasia was seen.
M.C.Raux Demay*, A.Dages*, F.Girard, ( Introd. by F.Girard ) .
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Lab. Explorations Fonctionnelles, H8pital Trousseau, 75012,Paris. France. CORTISOL ASSESSMENT OF BABIES BORN FROM MOTHERS TREATED BY GLUCOCORTICOIDS Basal and stimulated (IM .125 ug of short-acting Synacthen) Cortisol (F) levels were evaluated in 34 babies (Tle_ged) born from mothers treated with Glucocorticoid [Prednisone (5-100) or Bethametasone (.5-3.5) mg/day] either over the whole pregnancy or the last 1-22 weeks. Results were compared with agematched Control groups (Wilcoxon test). In spite of the 50% Basal F values lower than 60 ng/ml observed in the 0-90 (n=80) 3 children with Cushing synd~ome aged 9 to 1 5 were treated with o,pl-DDD (Lysodren ) for 5 to 10 years. The drug lowers plasma cortisol by stimulating the microsomal enzyme system of the liver. In addition it has a direct cytotoxic effect on the adrenal cortex. Initial dosage was 25 -45 mg/kg; maintenance dosage 1 5 -20 mg/kg body weigth. The treatment was monitored by measuring the plasma concentration of cortisol and o,p'-DDD and its metabolit 0.p'-DDE according to needs. Clinical remission was achieved in 12 weeks. Good long standing clinical results with normal plasma cortisol, diminished cortisol response to ACTH, and without clinical side effects were obtained at a plasma concentration of o,pl-DDD of 5 to 10pg/ml. finder treatment one of the patients became pregnant and delivered a healthy newborn. It is concluded that o,p'-DDD in low dosage and additional gc determination of its plasma level allow to control Cushing syndrome over long peroids of time without clinical side effects.
